Development and characterization of pilocarpine loaded eudragit nanosuspensions for ocular drug delivery

Journal of Biomedical Nanotechnology

Volumn 9, Issue 1, 2013, Pages 124-131

  Khan, Mohammed S ^a   Vishakante, Gowda D ^a   Bathool, Afifa ^a  

^a JSS COLLEGE OF PHARMACY   (India)

Author keywords

Eudragit; Nanosuspensions; Ocular Delivery; Zeta Potential

Indexed keywords

AVERAGE PARTICLE SIZE; DRUG LOADED NANOPARTICLE; EUDRAGIT; NANO-SUSPENSIONS; OCULAR DELIVERY; POLYDISPERSITY INDICES; SOLVENT DISPLACEMENTS; TRANSMISSION ELECTRON MICROSCOPY (TEM);

DIFFERENTIAL SCANNING CALORIMETRY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; NANOPARTICLES; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

DRUG DELIVERY;

EUDRAGIT; PILOCARPINE; POLOXAMER; POLYMER; RESIN; SOLVENT;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG RELEASE; DRUG STABILITY; INFRARED SPECTROSCOPY; NANOSUSPENSION; NONHUMAN; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SOLVENT DISPLACEMENT METHOD; SUSPENSION; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EYE; MITOSIS; NANOPARTICLES; PARTICLE SIZE; PILOCARPINE; POLYMETHACRYLIC ACIDS; RABBITS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STATIC ELECTRICITY; SUSPENSIONS;

EID: 84876541363     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1475     Document Type: Article

References (42)

1. T. J. Zimmerman, Pilocarpine. Ophthalmology 88, 85 (1981).
2. H. J. Kao, H. R. Lin, Y. L. Lo, and S. P. Yu, Characterization of pilocarpine-loaded chitosan/Carbopol nanoparticles. JPP 58, 179 (2006).
3. V. H. Lee, Review: New directions in the optimization of ocular drug delivery. J. Ocul. Pharmacol. 6, 157 (1990).
4. T. Harmia, J. Kreuter, and P. Speiser, Optimization of pilocarpine loading on to nanoparticles by sorption procedures. Inr. J. Phurm. 33, 45 (1986a).
5. M. Juslin, A. Urtti, and L. Salminen, Deiiverial and pharmacokinetic aspects of ocular drug therapy. Acru. Phurm. Few 90, 289 (1981).
6. T. Harmia, J. Kreuter, and P. Speiser, A solid colloidal drug delivery system for the eye: Encapsulation of pilocarpine in nanoparticles. J. Microencapsul. 3, 3 (1986).
7. R. Gref, Y. Minamitake, M. T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer, Biodegradable long-circulating polymeric nanospheres. Science 263, 1600 (1994).
8. A. Zimmer, E. Mutschler, G. Lambrecht, D. Mayer, and J. Kreuter, Pharmacokinetic and pharmacodynamic aspects of an ophthalmic pilocarpine nanoparticle-delivery-system. Pharm. Res. 11, 1435 (1994).
9. L. M. Heussler, P. Maincent, M. Hoffman, and D. Sirbat, Value of the new drug carriers in ophthalmology: Liposomes and nanoparticles. J. Fr. Ophtalmol. 13, 575 (1990).
10. F. Castelli, C. Messina, M. G. Sarpietro, R. Pignatello, and G. Puglisi, Flurbiprofen release from eudragit RS and RL aqueous nanosuspensions: A kinetic study by DSC and dialysis experiments. AAPS Pharm. Sci. Tech. 2, 2 (2002).
11. R. Pignatello, C. Bucolo, G. Spedalieri, A. Maltese, and G. Puglisi, Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application. Biomaterials 23, 3247 (2002).
12. R. Pignatello, C. Bucolo, G. Spedalieri, A. Maltese, and G. Puglisi, Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur. J. Pharm. Sci. 16, 53 (2002).
13. R. Pignatello, N. Ricupero, C. Bucolo, F. Maugeri, A. Maltese, and G. Puglisi, Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene. AAPS Pharm. Sci. Tech. 7, 27 (2006).
14. S. Das, P. K. Suresh, and R. Desmukh, Design of Eudragit® RL 100 nanoparticles by nanoprecipitation method for for ocular drug delivery. Nanomedicine: NBM 6, 318 (2010).
15. R. Pignatello, C. Bucolo, and G. Puglisi, Ocular tolerability of Eudragit RS100® and RL100® nanosuspensions as carriers for ophthalmic controlled drug delivery. J. Pharm. Sci. 91, 2636 (2002).
16. K. J. Huei, L. R. Hong, and Y. Shi, Characterization of pilocarpineloaded chitosan/carbopol nanoparticles. Drug Dev. Ind. Pharm. 58, 179 (2006).
17. D. C. Fu, Y. S. Ming, Y. G. Ben, F. Y. Ling, W. Liang, Y. Peng, and Y. He, Int. J. Pharm. 259, 103 (2003).
18. T. P. Hadjiioannou, G. D. Christian, and M. A. Koupparis, Quantitative Calculations in. Pharmaceutical Practice and Research, VCH Publishers Inc., New York, NY (1993), Vols. 345-348, p. 177.
19. J. G. Wagner, Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J. Pharm. Sci. 58, 1253 (1969).
20. D. W. Bourne, G. S. Banker, and C. T. Rhodes (eds.), Modern Pharmaceutics, 4th edn., Marcel Dekker Inc., New York (2002), pp. 67-92.
21. M. Gibaldi and S. Feldman, Establishment of sink conditions in dissolution rate determinations: Theoretical considerations and application to nondisintegrating dosage forms. J. Pharm. Sci. 56, 1238 (1967).
22. T. Higuchi, Mechanism of sustained action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 52, 1145 (1963).
23. T. Higuchi, Rate of release of medicaments from ointment bases containing drugs in suspension. J. Pharm. Sci. 50, 874 (1961).
24. J. Cobby, M. Mayersohn, and G. C. Walker, Influence of shape factors on kinetics of drug release from matrix tablets. II. Experimental. J. Pharm. Sci. 63, 732 (1974).
25. A. W. Hixson and J. H. Crowell, Dependence of reaction velocity upon surface and agitation: I-theoretical consideration. Ind. Eng. Chem. Res. 23, 923 (1931).
26. R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri. N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 15, 25 (1983).
27. N. A. Peppas, Analysis of Fickian and non-Fickian drug release from polymers. Pharmaceutica Acta Helvetiae 60, 110 (1985).
28. R. S. Harland, A. Gazzaniga, M. E. Sangalli, P. Colombo, and N. A. Peppas, Drug/polymer matrix swelling and dissolution. Pharma. Res. 5, 488 (1988).
29. J. Siepmann and N. A. Peppas, Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). ADDR 48, 139 (2001).
30. H. Fessi, F. Puisieux, J. P. Devissaguet, N. Ammoury, and S. Benita, Nanocapsule formation by interfacial deposition following solvent displacement. Int. J. Pharm. 55, R1 (1989).
31. J. M. Barichello, M. Morishita, and K. Takayama, Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev. Ind. Pharm. 25, 471 (1999).
32. R. S. Galindo, E. Allémann, H. Fessi, and E. Doelker, Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm. Res. 21, 1428 (2004).
33. F. Ganachaud and J. L. Katz, Nanoparticles and nanocapsules created using the ouzo effect: Spontaneous emulsification as an alternative to ultrasonic and high-shear devices. Chem. Phys. Chem. 6, 209 (2005).
34. G. D. Quintanar, E. Alle'mann, H. Fessi, and E. Doelker, Preparation techniques and mechanism of formation of biodegradable nanoparticles from preformed polymers. Drug Dev. Ind. Pharm. 24, 1113 (1998).
35. W. Mecklenburg, The relation between the Tyndall effect and the size of the particles of colloidal solutions. Kolloid-Zeitschrift 16, 97 (1915).
36. A. Zimmer and J. Kreuter, Microspheres and nanoparticles used in ocular delivery systems. ADDR 16, 61 (1995).
37. M. Nidhin, R. Indumathy, K. J. Sreeram, and U. N. Balachandran, Synthesis of iron oxide nanoparticles of narrow size distribution on polysaccharide templates. Bull. Mater. Sci. 31, 93 (2008).
38. H. L. Marchal, P. Maincent, M. Hoffman, J. Spittler, and P. Couvreur, Antiglaucomatous activity of betaxolol chlorhydrate sorbed onto different isobutylcyanoacrylate nanoparticle preparations. Int. J. Pharm. 58, 115 (1990).
39. S. Rathode and S. G. Deshpande, Albumin microspheres as an ocular delivery system for pilocarpine nitrate. Indian J. Pharm. Sci. 70, 193 (2008).
40. R. Pignatello, C. Bucolo, G. Spedalieri, A. Maltese, and G. Puglisi, Flurbiprofen-loaded acrylate polymernanosuspensions for ophthalmic application. Biomaterials 23, 3247 (2002).
41. G. Russell, H. F. Edelhauser, and L. Diane, The pH tolerance of rabbit and human corneal endothelium. Invest. Ophthaltnol. Visual Sri. 18, 210 (1979).
42. A. K. Zimmer, H. Zerbe, and J. J. Kreuter, Evaluation of pilocarpineloaded albumin particles as drug delivery systems for controlled delivery in the eye I. In vitro and in vivo characterization. J. Control Release 32, 57 (1994).